First Loci technology-based PSA assays.
With PSA testing on the rise as prostate cancer awareness grows, labs can consolidate this testing on the Dimension Vista[R] 1500 Intelligent Lab System. Two new high-precision assays aid in the detection of prostate cancer: Total PSA (TPSA) and free PSA (FPSA), for use on the Vista system, offer high sensitivity, quick reaction times, low sample volumes, and simpler homogenous processing, with no washing or separation steps. The assays employ LOCI[R] technology, which uses an oxygen channeling mechanism that provides unlimited signal generation and requires fewer reaction steps, resulting in fast turnaround times.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Industry spotlight|
|Publication:||Medical Laboratory Observer|
|Date:||Apr 1, 2012|
|Previous Article:||Prevention of perinatal group B streptococcal disease: highlights from revised CDC guidelines (2010).|
|Next Article:||Selectra ProM chemistry system supports laboratory diagnostics.|